IP Library › Granted Patent US 9,751,986
Granted Patent B2
US 9,751,986 · App. 14/365,459 · Granted Sep 5, 2017

Low toxicity solvent system for polyamideimide resins and solvent system manufacture

Inventors: John Sidenstick (Newport, TN); David Noga (Spring City, TN); Kathryn Mullins (Soddy Daisy, TN); Mace Phillips (Hixson, TN)
Assignee: FUJIFILM HUNT CHEMICALS US, INC.
C08G73/14C08G73/1003C09D7/001C09D179/08C08L79/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,751,986
App. No.
14/365,459
Granted
Sep 5, 2017
Kind
B2
Abstract

Disclosed is a low toxicity aprotic alkyl amide solvent system used for the manufacture and application of polyamideimide resins, and an efficient method for manufacturing the polyamideimide resins in a solvent system in a single reaction with distillation which allows recycling of intermediate streams. The solvent system can be used for either the manufacture or the dissolution of polyamideimide resins.

Claims (18)

1. A process for producing polyamideimide comprising using at least one aprotic dialkylamide solvent, wherein the at least one aprotic dialkylamide solvent includes diacetylpiperazine or N,N-diisopropylacetamide;

wherein a ratio of the at least one aprotic dialkylamide solvent to other process co-solvents is between 19:1 and 1:1; and

wherein the other process co-solvents are selected from the group consisting of water, o-xylene, triethylamine, dimethylethanolamine, morpholine, N-methylmorpholine, acetone, trimethylamine, tripropylamine, diethylamine, diisopropylamine, and caprolactam.

2. The process of claim 1 wherein the at least one aprotic dialkylamide solvent further comprises N-acetyl morpholine.

3. The process of claim 1 wherein the at least one aprotic dialkylamide solvent further comprises diethyl acetamide.

4. The process of claim 1 wherein the at least one aprotic dialkylamide solvent further comprises di-N-propyl acetamide.

5. The process of claim 1 wherein the at least one aprotic dialkylamide solvent further comprises N-formyl morpholine.

6. The process of claim 1 wherein the at least one aprotic dialkylamide solvent further comprises di-N-butylacetamide.

7. The process of claim 1 wherein the at least one aprotic dialkylamide solvent further comprises N-propionyl morpholine.

8. A polyamideimide product produced by the process of claim 1 .

9. The process of claim 1 , further comprising:

reacting a diisocyanate with a trimellitic anhydride (TMA) in the presence of the at least one aprotic dialkylamide solvent.

10. The method of claim 1 , wherein a molar ratio of a total amount of the at least one aprotic dialkylamide solvent to a total amount of other process co-solvents is approximately 78:22.

11. The method of claim 1 , wherein the diisocyanate is 4,4′-methylene diphenyldiisocyanate (MDI).

12. A polyamideimide product produced by the process of claim 9 .

13. A process for producing polyamideimide comprising using at least one aprotic dialkylamide solvent, wherein the at least one aprotic dialkylamide solvent includes N-acetyl morpholine, diethyl acetamide, di-N-propyl acetamide, N-formyl morpholine, diacetylpiperazine, N,N-diisopropylacetamide, di-N-butylacetamide or N-propionyl morpholine;

wherein a molar ratio of the at least one aprotic dialkylamide solvent to other process co-solvents is approximately 78:22; and

wherein the other process co-solvents are selected from the group consisting of water, o-xylene, triethylamine, dimethylethanolamine, morpholine, N-methylmorpholine, acetone, trimethylamine, tripropylamine, diethylamine, diisopropylamine, and caprolactam.

Assignments (1)
ASSET PURCHASE AGREEMENT Recorded Sep 20, 2017
From: FUJIFILM HUNT CHEMICALS USA, INC.
To: CYMER-DAYTON, LLC
Reel/Frame 043924/0026 →
Continuity (2)
Provisional Application 61576247 · Dec 15, 2011
Related Publication 20160002408A1 · Jan 7, 2016